Published in Radiology on March 01, 1996
Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment | NCT00061347
ESUR prostate MR guidelines 2012. Eur Radiol (2012) 8.86
Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res (2008) 4.79
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. Radiology (2010) 3.12
The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer (2006) 2.70
Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging (2002) 2.64
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology (2010) 2.38
The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy. Oncology (2000) 2.36
hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer (2005) 2.21
[(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy. Eur J Nucl Med Mol Imaging (2008) 1.96
Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol (2009) 1.89
Imaging techniques for prostate cancer: implications for focal therapy. Nat Rev Urol (2009) 1.76
Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging (2013) 1.54
Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. Radiology (2009) 1.48
Citrate in the diagnosis of prostate cancer. Prostate (1999) 1.44
MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. Int J Radiat Oncol Biol Phys (2004) 1.44
Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia (2000) 1.34
Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology (2005) 1.30
Multimodal wavelet embedding representation for data combination (MaWERiC): integrating magnetic resonance imaging and spectroscopy for prostate cancer detection. NMR Biomed (2011) 1.29
Kinetics of [(11)C]choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging (2003) 1.27
Advances in MR spectroscopy of the prostate. Magn Reson Imaging Clin N Am (2008) 1.24
Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging (2006) 1.22
Metabolic tumor imaging using magnetic resonance spectroscopy. Semin Oncol (2011) 1.22
Multi-kernel graph embedding for detection, Gleason grading of prostate cancer via MRI/MRS. Med Image Anal (2012) 1.20
Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy. Eur J Nucl Med Mol Imaging (2005) 1.17
MR imaging of the prostate in clinical practice. MAGMA (2008) 1.15
Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging. Radiology (2009) 1.14
Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging. Curr Urol Rep (2010) 1.11
Zinc is decreased in prostate cancer: an established relationship of prostate cancer! J Biol Inorg Chem (2010) 1.11
Prostatic fluid electrolyte composition for the screening of prostate cancer: a potential solution to a major problem. Prostate Cancer Prostatic Dis (2008) 1.09
Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder. J Rehabil Res Dev (2009) 1.08
Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer. Chem Rev (2010) 1.06
Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.05
MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer. NMR Biomed (2011) 1.03
Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles. Clin Cancer Res (2009) 1.03
Highly-accelerated quantitative 2D and 3D localized spectroscopy with linear algebraic modeling (SLAM) and sensitivity encoding. J Magn Reson (2013) 1.03
Prostate MRI and 3D MR spectroscopy: how we do it. AJR Am J Roentgenol (2010) 1.02
A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS). Med Phys (2009) 1.00
Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer. Top Magn Reson Imaging (2008) 0.99
New horizons in prostate cancer imaging. Eur J Radiol (2008) 0.99
Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. Cancer Res (2014) 0.98
Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors. Neoplasia (2007) 0.97
Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer. MAGMA (2000) 0.97
Imaging transgene activity in vivo. Cancer Res (2008) 0.97
Magnetic resonance imaging and spectroscopy of prostate cancer. Rev Urol (2006) 0.95
Clinical utility of endorectal MRI-guided prostate biopsy: preliminary experience. J Magn Reson Imaging (2013) 0.95
A magnetic resonance spectroscopy driven initialization scheme for active shape model based prostate segmentation. Med Image Anal (2010) 0.92
A meta-analysis of the accuracy of prostate cancer studies which use magnetic resonance spectroscopy as a diagnostic tool. Korean J Radiol (2008) 0.89
Magnetic resonance spectroscopy detectable metabolomic fingerprint of response to antineoplastic treatment. PLoS One (2011) 0.89
In vivo monitoring response to chemotherapy of human diffuse large B-cell lymphoma xenografts in SCID mice by 1H and 31P MRS. Acad Radiol (2007) 0.89
Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a(1)H NMR study. Br J Cancer (2002) 0.89
Metabolomics: a novel approach to early and noninvasive prostate cancer detection. Korean J Urol (2011) 0.88
Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome. Br J Cancer (2004) 0.87
Evaluation of short-TE (1)H MRSI for quantification of metabolites in the prostate. NMR Biomed (2014) 0.87
Post-processing correction of the endorectal coil reception effects in MR spectroscopic imaging of the prostate. J Magn Reson Imaging (2010) 0.86
Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T--quantitative correlation with biopsy. Magn Reson Imaging (2010) 0.86
Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy. Br J Cancer (2013) 0.85
Lymphotropic nanoparticle enhanced MRI for the staging of genitourinary tumors. Nat Rev Urol (2010) 0.85
Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer. J Endourol (2008) 0.85
Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer. Radiology (2009) 0.85
Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r. Magn Reson Med (2009) 0.85
Innovations in diagnostic imaging of localized prostate cancer. World J Urol (2014) 0.84
MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer. BMC Cancer (2010) 0.83
Multi-Parametric MRI-Directed Focal Salvage Permanent Interstitial Brachytherapy for Locally Recurrent Adenocarcinoma of the Prostate: A Novel Approach. J Cancer (2013) 0.82
Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective. MAGMA (2008) 0.82
Value of magnetic resonance imaging in prostate cancer diagnosis. World J Urol (2007) 0.81
Toward adaptive stereotactic robotic brachytherapy for prostate cancer: demonstration of an adaptive workflow incorporating inverse planning and an MR stealth robot. Minim Invasive Ther Allied Technol (2010) 0.81
Two-dimensional MR spectroscopy of healthy and cancerous prostates in vivo. MAGMA (2008) 0.81
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment. Eur J Nucl Med Mol Imaging (2009) 0.80
Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate. Urol Res (2003) 0.80
A Critical Assessment of Epidemiology Studies Regarding Dietary/Supplemental Zinc and Prostate Cancer Risk. Open Urol Nephrol J (2008) 0.80
Novel Approaches to Imaging Tumor Metabolism. Cancer J (2015) 0.80
What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging? Eur Radiol (2015) 0.80
Lactate transporters in the context of prostate cancer metabolism: what do we know? Int J Mol Sci (2014) 0.79
Magnetic resonance imaging for prostate cancer clinical application. Chin J Cancer Res (2013) 0.79
In vivo proton MR spectroscopy of pancreatic neuroendocrine tumors in a multiple endocrine neoplasia type 1 conditional knockout mouse model. Magn Reson Med (2014) 0.78
3D proton MR spectroscopic imaging of prostate cancer using a standard spine coil at 1.5 T in clinical routine: a feasibility study. Eur Radiol (2004) 0.78
Accelerated echo planar J-resolved spectroscopic imaging in prostate cancer: a pilot validation of non-linear reconstruction using total variation and maximum entropy. NMR Biomed (2015) 0.78
Effect of Prostate Biopsy Hemorrhage on MRDW and MRS Imaging. Korean J Urol (2011) 0.78
TE = 32 ms vs TE = 100 ms echo-time (1)H-magnetic resonance spectroscopy in prostate cancer: Tumor metabolite depiction and absolute concentrations in tumors and adjacent tissues. J Magn Reson Imaging (2015) 0.78
Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate. Eur Radiol (2016) 0.77
Investigation of the PSF-choice method for reduced lipid contamination in prostate MR spectroscopic imaging. Magn Reson Med (2012) 0.77
Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer. Neoplasia (2007) 0.77
MR Imaging of Prostate Cancer: Diffusion Weighted Imaging and (3D) Hydrogen 1 (H) MR Spectroscopy in Comparison with Histology. Radiol Res Pract (2010) 0.77
MR Spectroscopic Imaging of Peripheral Zone in Prostate Cancer Using a 3T MRI Scanner: Endorectal versus External Phased Array Coils. Magn Reson Insights (2013) 0.77
Metabolomic imaging of prostate cancer with magnetic resonance spectroscopy and mass spectrometry. Eur J Nucl Med Mol Imaging (2013) 0.76
Imaging and intervention in prostate cancer: Current perspectives and future trends. Indian J Radiol Imaging (2014) 0.76
A positive magnetic resonance spectroscopic imaging with negative initial biopsy may predict future detection of prostate cancer. Indian J Urol (2012) 0.75
NMR SLIC Sensing of Hydrogenation Reactions Using Parahydrogen in Low Magnetic Fields. J Phys Chem C Nanomater Interfaces (2016) 0.75
Sodium 3D COncentration MApping (COMA 3D) using (23)Na and proton MRI. J Magn Reson (2014) 0.75
Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling. Am J Pathol (2016) 0.75
Planning primary therapy. Cancer Imaging (2000) 0.75
Multiparametric Magnetic Resonance Imaging Characteristics of Prostate Tuberculosis. Korean J Radiol (2015) 0.75
Endorectal coil MRI and MR-spectroscopic imaging in patients with elevated serum prostate specific antigen with negative trus transrectal ultrasound guided biopsy. Urol Ann (2013) 0.75
The role of metabolic imaging in radiation therapy of prostate cancer. NMR Biomed (2013) 0.75
Prostate MRSI predicts outcome in radical prostatectomy patients. Magn Reson Imaging (2016) 0.75
Multimodality imaging using proton magnetic resonance spectroscopic imaging and (18)F-fluorodeoxyglucose-positron emission tomography in local prostate cancer. World J Radiol (2017) 0.75
The representation of meaning in the UMLS. Methods Inf Med (1995) 12.85
The NLM Indexing Initiative. Proc AMIA Symp (2000) 11.40
Beyond synonymy: exploiting the UMLS semantics in mapping vocabularies. Proc AMIA Symp (1998) 6.28
Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54
Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci U S A (1995) 5.25
The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med (1996) 5.06
Adding your terms and relationships to the UMLS Metathesaurus. Proc Annu Symp Comput Appl Med Care (1991) 4.54
A randomized controlled trial and economic evaluation of counselling in primary care. Br J Gen Pract (1998) 3.84
Navigating to knowledge. Methods Inf Med (1995) 3.69
In vivo 13 carbon metabolic imaging at 3T with hyperpolarized 13C-1-pyruvate. Magn Reson Med (2007) 3.58
Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature (1992) 3.39
Merging terminologies. Medinfo (1995) 2.91
Slow persistent infection caused by visna virus: role of host restriction. Science (1977) 2.83
Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol (2000) 2.73
Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim (1995) 2.63
A poor precedent. Methods Inf Med (1996) 2.55
Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (1994) 2.53
Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology (2002) 2.49
High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest (1998) 2.47
Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med (2000) 2.45
Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol (2001) 2.34
Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. Radiology (1999) 2.32
FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29
Imaging prostate cancer. Radiol Clin North Am (2000) 2.20
Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice. Proc Natl Acad Sci U S A (1996) 2.10
Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation (2001) 2.10
MEME-II supports the cooperative management of terminology. Proc AMIA Annu Fall Symp (1996) 2.06
Pneumothorax in the newborn. Neonatal Netw (1991) 2.03
MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol (2006) 2.00
Formal properties of the Metathesaurus. Proc Annu Symp Comput Appl Med Care (1994) 1.97
Association of renal agenesis and mullerian duct anomalies. J Comput Assist Tomogr (2000) 1.95
Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology (1985) 1.93
The homogenization of the Metathesaurus schema and distribution format. Proc Annu Symp Comput Appl Med Care (1992) 1.87
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature (2001) 1.84
Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology. Urology (2001) 1.83
Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology (1999) 1.82
Prostate cancer imaging. Acta Radiol (2008) 1.82
A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol (1992) 1.80
Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor. Nature (1990) 1.80
Management of the fetus with congenital hydronephrosis. J Pediatr Surg (1982) 1.79
Evaluating RECONSIDER. A computer program for diagnostic prompting. J Med Syst (1985) 1.75
Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. AJNR Am J Neuroradiol (2001) 1.73
Imaging considerations for in vivo 13C metabolic mapping using hyperpolarized 13C-pyruvate. Magn Reson Med (2009) 1.72
Detection of herpesvirus DNA in vitreous and aqueous specimens by the polymerase chain reaction. Arch Ophthalmol (1991) 1.70
Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging. Magn Reson Med (2001) 1.70
A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res (2000) 1.70
Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy. Neurology (2004) 1.67
Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol (1999) 1.67
Biomedical database inter-connectivity: an experiment linking MIM, GENBANK, and META-1 via MEDLINE. Proc Annu Symp Comput Appl Med Care (1991) 1.61
Lipomatous tumors and tumors with fatty component: MR imaging potential and comparison of MR and CT results. Radiology (1985) 1.60
Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (1994) 1.58
Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA (1997) 1.56
Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology (1995) 1.53
N6-methyladenosine residues in an intron-specific region of prolactin pre-mRNA. Mol Cell Biol (1990) 1.52
Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant. Cancer (1998) 1.52
Sonographic findings in perforation of the gallbladder. AJR Am J Roentgenol (1982) 1.51
Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis. Crit Care Med (1997) 1.49
Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria. J Immunol (1985) 1.49
Prostatectomy tissue for research: balancing patient care and discovery. Am J Clin Pathol (1998) 1.48
Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology (1998) 1.48
An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma. J Magn Reson Imaging (2001) 1.48
Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol (2007) 1.47
Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med (1995) 1.47
Magnetic resonance imaging with respiratory gating: techniques and advantages. AJR Am J Roentgenol (1984) 1.46
Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI. Neurology (2010) 1.46
High-resolution surface-coil MR of cortical lesions in medically refractory epilepsy: a prospective study. AJNR Am J Neuroradiol (1997) 1.45
Citrate in the diagnosis of prostate cancer. Prostate (1999) 1.44
Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology (1997) 1.43
A second DNA methyltransferase repair enzyme in Escherichia coli. Proc Natl Acad Sci U S A (1988) 1.42
Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. Am Fam Physician (2001) 1.42
The future of research in genitourinary radiology: through the looking glass--a view from the Society of Uroradiology. Radiology (1998) 1.41
Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex. J Biol Chem (1994) 1.39
Electrocardiographic abnormalities suggestive of myocardial ischemia during upper gastrointestinal bleeding. Am J Cardiol (1995) 1.39
Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol (1995) 1.39
Phased array detectors and an automated intensity-correction algorithm for high-resolution MR imaging of the human brain. Magn Reson Med (1995) 1.39
Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med (2005) 1.38
Clinical application of pulse oximetry. Pediatr Nurs (1993) 1.38
Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol (1987) 1.38
Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain (2008) 1.37
Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neurol (1994) 1.36
In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors. J Magn Reson (1998) 1.35
MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys (2001) 1.35
The Escherichia coli AlkB protein protects human cells against alkylation-induced toxicity. J Bacteriol (1994) 1.35
Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia (2000) 1.34
Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. Radiology (1994) 1.33